Tom Clegg

Tom Clegg

Auto-generated profile, based on publicly available information

Tom Clegg

Harvard Personal Genome Project, Harvard Medical School, NRB 238, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MBMadeleine P. Ball
Madeleine P. Ball
JTJoseph V. Thakuria
Joseph V. Thakuria
AZAlexander Wait Zaranek
Alexander Wait Zaranek
TCTom Clegg
Tom Clegg
ARAbraham M. Rosenbaum
Abraham M. Rosenbaum
GCGeorge Church
George Church
Rapid advances in DNA sequencing promise to enable new diagnostics and individualized therapies. Achieving personalized medicine, however, will require extensive research on highly reidentifiable, integrated datasets of genomic and health information. To assist with this, participants in the Personal Genome Project choose to forgo privacy via our institutional review board- approved “open consent” process. The contribution of public data and samples facilitates both scientific discovery and standardization of methods. We present our findings after enrollment of more than 1,800 participants, including whole-genome sequencing of 10 pilot participant genomes (the PGP-10). We introduce the Genome-Environment-Trait Evidence (GET-Evidence) system. This tool automatically processes genomes and prioritizes both published and novel variants for interpretation. In the process of reviewing the presumed healthy PGP-10 genomes, we find numerous literature references implying serious disease. Although it is sometimes impossible to rule out a late-onset effect, stringent evidence requirements can address the high rate of incidental findings. To that end we develop a peer production system for recording and organizing variant evaluations according to standard evidence guidelines, creating a public forum for reaching consensus on interpretation of clinically relevant variants. Genome analysis becomes a two-step process: using a prioritized list to record variant evaluations, then automatically sorting reviewed variants using these annotations. Genome data, health and trait information, participant samples, and variant interpretations are all shared in the public domain—we invite others to review our results using our participant samples and contribute to our interpretations. We offer our public resource and methods to further personalized medical research.

28 February 2014 in Genome Medicine
Verified
Journal Article
Open access
PDF file
MBMadeleine P Ball
Madeleine P Ball
JBJason R Bobe
Jason R Bobe
MCMichael F Chou
Michael F Chou
TCTom Clegg
Tom Clegg
PEPreston W Estep
Preston W Estep
GCGeorge Church
George Church
Background: Since its initiation in 2005, the Harvard Personal Genome Project has enrolled thousands of volunteers interested in publicly sharing their genome, health and trait data. Because these data are highly identifiable, we use an ‘open consent’ framework that purposefully excludes promises about privacy and requires participants to demonstrate comprehension prior to enrollment. Discussion: Our model of non-anonymous, public genomes has led us to a highly participatory model of researcher-participant communication and interaction. The participants, who are highly committed volunteers, self-pursue and donate research-relevant datasets, and are actively engaged in conversations with both our staff and other Personal Genome Project participants. We have quantitatively assessed these communications and donations, and report our experiences with returning research-grade whole genome data to participants. We also observe some of the community growth and discussion that has occurred related to our project. Summary: We find that public non-anonymous data is valuable and leads to a participatory research model, which we encourage others to consider. The implementation of this model is greatly facilitated by web-based tools and methods and participant education. Project results are long-term proactive participant involvement and the growth of a community that benefits both researchers and participants.

20 May 2010 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
AZAlexander Wait Zaranek
Alexander Wait Zaranek
ELErez Y. Levanon
Erez Y. Levanon
TZTomer Zecharia
Tomer Zecharia
TCTom Clegg
Tom Clegg
GCGeorge Church
George Church
While it is widely held that an organism's genomic information should remain constant, several protein families are known to modify it. Members of the AID/APOBEC protein family can deaminate DNA. Similarly, members of the ADAR family can deaminate RNA. Characterizing the scope of these events is challenging. Here we use large genomic data sets, such as the two billion sequences in the NCBI Trace Archive, to look for clusters of mismatches of the same type, which are a hallmark of editing events caused by APOBEC3 and ADAR. We align 603,249,815 traces from the NCBI trace archive to their reference genomes. In clusters of mismatches of increasing size, at least one systematic sequencing error dominates the results (G-to-A). It is still present in mismatches with 99% accuracy and only vanishes in mismatches at 99.99% accuracy or higher. The error appears to have entered into about 1% of the HapMap, possibly affecting other users that rely on this resource. Further investigation, using stringent quality thresholds, uncovers thousands of mismatch clusters with no apparent defects in their chromatograms. These traces provide the first reported candidates of endogenous DNA editing in human, further elucidating RNA editing in human and mouse and also revealing, for the first time, extensive RNA editing in Xenopus tropicalis. We show that the NCBI Trace Archive provides a valuable resource for the investigation of the phenomena of DNA and RNA editing, as well as setting the stage for a comprehensive mapping of editing events in large-scale genomic datasets. Most biomedical, genomic research begins with the painstaking assembly of a “reference genome” for the organism of interest. Implicit in this process is an assumption that genomic information is constant throughout an organism. There are enzymes, however, that can change, or “edit,” genomic information so that variations from the reference can exist within a single organism. In this work, we analyze the raw data used to assemble the reference genomes of ten organisms to discover evidence for editing. We found candidates for DNA and RNA editing as well as a sequencing error that has become incorporated into commonly used genomic resources. Our analysis demonstrates the utility of raw genomic data for the discovery of some editing events and sets the stage for further analysis as sequencing costs continue to decrease exponentially.

11 October 2016 in GigaScience
Verified
Journal Article
Open access
PDF file
QMQing Mao
Qing Mao
SCSerban Ciotlos
Serban Ciotlos
RZRebecca Yu Zhang
Rebecca Yu Zhang
MBMadeleine P Ball
Madeleine P Ball
RCRobert Chin
Robert Chin
BPBrock A Peters
Brock A Peters
Background: Since the completion of the Human Genome Project in 2003, it is estimated that more than 200,000 individual whole human genomes have been sequenced. A stunning accomplishment in such a short period of time. However, most of these were sequenced without experimental haplotype data and are therefore missing an important aspect of genome biology. In addition, much of the genomic data is not available to the public and lacks phenotypic information. Findings: As part of the Personal Genome Project, blood samples from 184 participants were collected and processed using Complete Genomics' Long Fragment Read technology. Here, we present the experimental whole genome haplotyping and sequencing of these samples to an average read coverage depth of 100X. This is approximately three-fold higher than the read coverage applied to most whole human genome assemblies and ensures the highest quality results. Currently, 114 genomes from this dataset are freely available in the GigaDB repository and are associated with rich phenotypic data; the remaining 70 should be added in the near future as they are approved through the PGP data release process. For reproducibility analyses, 20 genomes were sequenced at least twice using independent LFR barcoded libraries. Seven genomes were also sequenced using Complete Genomics' standard non-barcoded library process. In addition, we report 2.6 million high-quality, rare variants not previously identified in the Single Nucleotide Polymorphisms database or the 1000 Genomes Project Phase 3 data. Conclusions: These genomes represent a unique source of haplotype and phenotype data for the scientific community and should help to expand our understanding of human genome evolution and function.

1 May 2008
Verified
Conference Paper
Closed access
AZAlexander Wait Zaranek
Alexander Wait Zaranek
TCTom Clegg
Tom Clegg
WVWard Vandewege
Ward Vandewege
GCGeorge M. Church
George M. Church